Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1.

Saved in:
Bibliographic Details
Title: Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1.
Authors: Nicolodi C; AVIR Green Hills Biotechnology, 1200 Vienna, Austria. Electronic address: nicolodi.christina@gmail.com., Groiss F; AVIR Green Hills Biotechnology, 1200 Vienna, Austria., Kiselev O; Research Institute of Influenza, Russian Academy of Medical Sciences, St. Petersburg, Russia., Wolschek M; AVIR Green Hills Biotechnology, 1200 Vienna, Austria., Seipelt J; AVIR Green Hills Biotechnology, 1200 Vienna, Austria., Muster T; AVIR Green Hills Biotechnology, 1200 Vienna, Austria.
Source: Vaccine [Vaccine] 2019 Jun 19; Vol. 37 (28), pp. 3722-3729. Date of Electronic Publication: 2019 May 30.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2518
DOI:10.1016/j.vaccine.2019.05.013